Skip to main content

Table 4 Statistical analysis results and clinical significance assessment

From: Association of tracheal diameter with respiratory function and fibrosis severity in idiopathic pulmonary fibrosis patients

Parameter

Correlation Coefficient (r)

p-value

Effect Size

Clinical Significance

Subcricoid Measurements

    

Subcricoid AP vs. FVC%

-0.162

0.147

Small

Limited clinical relevance

Subcricoid AP vs. DLCO%

-0.038

0.738

Negligible

No clinical relevance

Subcricoid AP vs. GAP Index

0.318

0.003

Medium

Moderate clinical relevance*

Subcricoid Transverse vs. FVC%

-0.102

0.363

Small

Limited clinical relevance

Subcricoid Transverse vs. DLCO%

-0.054

0.632

Negligible

No clinical relevance

Subcricoid Transverse vs. GAP Index

0.312

0.004

Medium

Moderate clinical relevance*

Area Measurements

    

Subcricoid Area vs. FVC%

-0.124

0.287

Small

Limited clinical relevance

Subcricoid Area vs. DLCO%

-0.089

0.452

Negligible

No clinical relevance

Subcricoid Area vs. FVC/DLCO

0.218

0.049

Small

Potential clinical value†

Subcricoid Area vs. GAP Index

0.307

0.006

Medium

Moderate clinical relevance*

Carina Area vs. FVC%

-0.156

0.178

Small

Limited clinical relevance

Carina Area vs. DLCO%

-0.112

0.341

Small

Limited clinical relevance

Carina Area vs. FVC/DLCO

0.245

0.027

Small

Potential clinical value†

Carina Area vs. GAP Index

0.334

0.003

Medium

Moderate clinical relevance*

Main Bronchi Measurements

    

Right Main Bronchus Area vs. GAP Index

0.298

0.008

Small-Medium

Potential clinical value†

Left Main Bronchus Area vs. GAP Index

0.287

0.011

Small-Medium

Potential clinical value†

Other bronchial measurements

< 0.200

> 0.05

Small

Limited clinical relevance

Thoracic Measurements

    

Thoracic Diameter (all parameters)

< 0.200

> 0.05

Small

Limited clinical relevance

  1. Notes:
  2. Effect Size Interpretation: Negligible (r < 0.1), Small (r = 0.1–0.3), Medium (r = 0.3–0.5), Large (r > 0.5)
  3. *Moderate clinical relevance: Correlations that may be useful in clinical decision-making when combined with other parameters
  4. †Potential clinical value: Correlations that reached statistical significance but require further validation
  5. AP: Anteroposterior; FVC: Forced Vital Capacity; DLCO: Diffusing Capacity of the Lungs for Carbon Monoxide; GAP: Gender-Age-Physiology
  6. Effect size categorization based on Cohen’s criteria for correlation coefficients in clinical research